Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, FDA issued new guidance on its Prescription Drug User Fee Amendments (PDUFA VII) program…
Source: www.raps.org – Read more
StockWatch: C-Suite Shakeup, Phase III Plans Jolt Cardiff Investors
Cardiff Oncology (NASDAQ: CRDF) this past week trumpeted positive data via press release from a Phase II trial of its lead pipeline candidate, onvansertib, in
